Literature DB >> 17205367

A weight index for the standardized uptake value in 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography.

Joseph A Thie1, Karl F Hubner, Francis P Isidoro, Gary T Smith.   

Abstract

INTRODUCTION: Known errors in the standardized uptake value (SUV) caused by variations in subject weights W encountered can be corrected by lean body mass or body surface area (bsa) algorithms replacing W in calculations. However this is infrequently done. The aims of the work here are: quantify sensitivity to W, encourage SUV correction with an approach minimally differing from tradition, and show what improvements in the SUV coefficient of variation (cv) for a population can be expected.
METHODS: Selected for analyses were 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) SUV data from positron emission tomography (PET) and PET/computed tomography (CT) scans at the University of Tennessee as well as from the literature. A weight sensitivity index was defined as -n=slope of ln(SUV/W) vs. lnW. The portion of the SUV variability due to this trend is removed by using the defined [formula: see text], or a virtually equal SUVm using [formula: see text], with Q and ID being tissue specific-activity and injected dose. [formula: see text] measures performance. Adapting to animal studies' tradition, [formula: see text] is preferred over the conventional [formula: see text].
RESULTS: For FDG in adults [formula: see text] from averaging over most tissues. In children, however, [formula: see text]. Tissues have the same index if their influx constants are independent of W. Suggested, therefore, is a very simplified [formula: see text], which is dimensionless and keeps the same population averages as traditional SUVs. It achieves [formula: see text]. Hence, for cv's of SUVs below approximately 1/3 improvements over tradition are possible, leading to F's<0.95. Accounting additionally for height, as in SUVbsa, gives very little improvement over the simplified approach here and gives essentially the same F's as SUVm.
CONCLUSIONS: Introduced here is a weight index useful in reducing variability and further understanding the SUV. Addressing weight sensitivity is appropriate where the cv of the SUVs is below about 1/3. Proposed is the very simple approach of using an average of an adult patient's weight and approximately 70 kg for FDG SUV calculations. Unlike other approaches the dimensionless population average of SUVms is unchanged from tradition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17205367     DOI: 10.1007/s11307-006-0068-x

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  17 in total

1.  Noninvasive estimation of FDG input function for quantification of cerebral metabolic rate of glucose: optimization and multicenter evaluation.

Authors:  T Shiozaki; N Sadato; M Senda; K Ishii; T Tsuchida; Y Yonekura; H Fukuda; J Konishi
Journal:  J Nucl Med       Date:  2000-10       Impact factor: 10.057

2.  Standardized uptake value in pediatric patients: an investigation to determine the optimum measurement parameter.

Authors:  H W Yeung; A Sanches; O D Squire; H A Macapinlac; S M Larson; Y E Erdi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2001-11-22       Impact factor: 9.236

3.  Anatomy of SUV. Standardized uptake value.

Authors:  S C Huang
Journal:  Nucl Med Biol       Date:  2000-10       Impact factor: 2.408

4.  Comparison of simplified quantitative analyses of FDG uptake.

Authors:  M M Graham; L M Peterson; R M Hayward
Journal:  Nucl Med Biol       Date:  2000-10       Impact factor: 2.408

5.  Standardized uptake values of fluorine-18 fluorodeoxyglucose: the value of different normalization procedures.

Authors:  A Schomburg; H Bender; C Reichel; T Sommer; J Ruhlmann; B Kozak; H J Biersack
Journal:  Eur J Nucl Med       Date:  1996-05

6.  Metabolism of [13N]ammonia in rat lung.

Authors:  Arthur J L Cooper; Barry R Freed
Journal:  Neurochem Int       Date:  2005-07       Impact factor: 3.921

7.  Evaluation of various corrections to the standardized uptake value for diagnosis of pulmonary malignancy.

Authors:  Y Menda; D L Bushnell; M T Madsen; K McLaughlin; D Kahn; K H Kernstine
Journal:  Nucl Med Commun       Date:  2001-10       Impact factor: 1.690

8.  The diagnostic utility of the lognormal behavior of PET standardized uptake values in tumors.

Authors:  J A Thie; K F Hubner; G T Smith
Journal:  J Nucl Med       Date:  2000-10       Impact factor: 10.057

9.  Standardized uptake values of FDG: body surface area correction is preferable to body weight correction.

Authors:  C K Kim; N C Gupta; B Chandramouli; A Alavi
Journal:  J Nucl Med       Date:  1994-01       Impact factor: 10.057

10.  Non-invasive estimation of the net influx constant using the standardized uptake value for quantification of FDG uptake of tumours.

Authors:  N Sadato; T Tsuchida; S Nakaumra; A Waki; H Uematsu; N Takahashi; N Hayashi; Y Yonekura; Y Ishii
Journal:  Eur J Nucl Med       Date:  1998-06
View more
  7 in total

1.  Study of an image-derived SUV and a modified SUV using mouse FDG-PET.

Authors:  Xiujuan Zheng; Chin-Lung Yu; Wei Sha; Caius Radu; Sung-Cheng Huang; Dagan Feng
Journal:  Nucl Med Biol       Date:  2010-12-03       Impact factor: 2.408

2.  Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa.

Authors:  Cindy Casteels; Nathalie Gérard; Kris van Kuyck; Lies Pottel; Bart Nuttin; Guy Bormans; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-05       Impact factor: 9.236

3.  Impacts of biological and procedural factors on semiquantification uptake value of liver in fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging.

Authors:  Mohd Hafizi Mahmud; Abdul Jalil Nordin; Fathinul Fikri Ahmad Saad; Ahmad Zaid Fattah Azman
Journal:  Quant Imaging Med Surg       Date:  2015-10

4.  Preclinical evaluation and quantification of [¹⁸F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain.

Authors:  Cindy Casteels; Michel Koole; Sofie Celen; Guy Bormans; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-15       Impact factor: 9.236

5.  Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 PET study.

Authors:  J Ceccarini; N Weltens; H G Ly; J Tack; L Van Oudenhove; K Van Laere
Journal:  Transl Psychiatry       Date:  2016-07-12       Impact factor: 6.222

6.  Modular Medical Imaging Agents Based on Azide-Alkyne Huisgen Cycloadditions: Synthesis and Pre-Clinical Evaluation of 18 F-Labeled PSMA-Tracers for Prostate Cancer Imaging.

Authors:  Verena I Böhmer; Wiktor Szymanski; Keimpe-Oeds van den Berg; Chantal Mulder; Piermichele Kobauri; Hugo Helbert; Dion van der Born; Friederike Reeβing; Anja Huizing; Marten Klopstra; Douwe F Samplonius; Ines F Antunes; Jürgen W A Sijbesma; Gert Luurtsema; Wijnand Helfrich; Ton J Visser; Ben L Feringa; Philip H Elsinga
Journal:  Chemistry       Date:  2020-07-21       Impact factor: 5.236

7.  The Effects of Physiological and Methodological Determinants on 18F-FDG Mouse Brain Imaging Exemplified in a Double Transgenic Alzheimer Model.

Authors:  Steven Deleye; Ann-Marie Waldron; Jill C Richardson; Mark Schmidt; Xavier Langlois; Sigrid Stroobants; Steven Staelens
Journal:  Mol Imaging       Date:  2016-02-11       Impact factor: 4.488

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.